Literature DB >> 10233976

Colocalization of the herpes simplex virus 1 UL4 protein with infected cell protein 22 in small, dense nuclear structures formed prior to onset of DNA synthesis.

S Jahedi1, N S Markovitz, F Filatov, B Roizman.   

Abstract

Herpes simplex virus 1 infected cell protein 22 (ICP22) localizes in small, dense nuclear bodies of primate cells early in infection and in the more diffuse replicative complexes after the onset of DNA synthesis. UL4, a gamma2 protein, localizes in cytoplasm and in the small nuclear structures containing ICP22 but not in replicative complexes. In rabbit skin cells, both ICP22 and UL4 localize in the dense nuclear bodies late in infection. The results suggest that the small nuclear structures perform a function involving both proteins late in infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233976      PMCID: PMC112558     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides.

Authors:  R W Honess; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  Alternatively spliced mRNAs predicted to yield frame-shift proteins and stable intron 1 RNAs of the herpes simplex virus 1 regulatory gene alpha 0 accumulate in the cytoplasm of infected cells.

Authors:  K L Carter; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

3.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

4.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

5.  A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth.

Authors:  L E Post; B Roizman
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

6.  Interaction of herpes simplex virus 1 alpha regulatory protein ICP0 with elongation factor 1delta: ICP0 affects translational machinery.

Authors:  Y Kawaguchi; R Bruni; B Roizman
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Characterization of the UL4 gene product of herpes simplex virus type 2.

Authors:  H Yamada; Y M Jiang; S Oshima; K Wada; F Goshima; T Daikoku; Y Nishiyama
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

8.  The UL4 gene of herpes simplex virus type 1 is dispensable for latency, reactivation and pathogenesis in mice.

Authors:  P Y Jun; L I Strelow; R C Herman; H S Marsden; T Eide; L Haarr; D A Leib
Journal:  J Gen Virol       Date:  1998-07       Impact factor: 3.891

9.  Characterization of herpes simplex virus 1 alpha proteins 0, 4, and 27 with monoclonal antibodies.

Authors:  M Ackermann; D K Braun; L Pereira; B Roizman
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

10.  Herpes simplex virus 1 mutant deleted in the alpha 22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice.

Authors:  A E Sears; I W Halliburton; B Meignier; S Silver; B Roizman
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

View more
  15 in total

1.  Small dense nuclear bodies are the site of localization of herpes simplex virus 1 U(L)3 and U(L)4 proteins and of ICP22 only when the latter protein is present.

Authors:  N S Markovitz; B Roizman
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Sequence variation in the herpes simplex virus U(S)1 ocular virulence determinant.

Authors:  Aaron W Kolb; Timothy R Schmidt; David W Dyer; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-28       Impact factor: 4.799

3.  Sequential localization of two herpes simplex virus tegument proteins to punctate nuclear dots adjacent to ICP0 domains.

Authors:  Ian Hutchinson; Alison Whiteley; Helena Browne; Gillian Elliott
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Analysis of the cellular localization of herpes simplex virus 1 immediate-early protein ICP22.

Authors:  Wei Cun; Jie Chen; Ying Zhang; Long-ding Liu; Qi-han Li
Journal:  Virol Sin       Date:  2010-06-06       Impact factor: 4.327

5.  Molecular determinants responsible for the subcellular localization of HSV-1 UL4 protein.

Authors:  Wei-Wei Pan; Jing Long; Jun-Ji Xing; Chun-Fu Zheng
Journal:  Virol Sin       Date:  2011-10-07       Impact factor: 4.327

Review 6.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

7.  Herpes simplex virus reorganizes the cellular DNA repair and protein quality control machinery.

Authors:  Sandra K Weller
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

8.  The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo.

Authors:  Armin Baiker; Christoph Bagowski; Hideki Ito; Marvin Sommer; Leigh Zerboni; Klaus Fabel; John Hay; William Ruyechan; Ann M Arvin
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Identification of sequences in herpes simplex virus type 1 ICP22 that influence RNA polymerase II modification and viral late gene expression.

Authors:  Thomas W Bastian; Stephen A Rice
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

10.  Herpes simplex virus type 1 immediate-early protein ICP22 is required for VICE domain formation during productive viral infection.

Authors:  Thomas W Bastian; Christine M Livingston; Sandra K Weller; Stephen A Rice
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.